Applied DNA Sciences Inc.

NASDAQ: APDN · Real-Time Price · USD
3.90
-0.17 (-4.18%)
At close: Aug 15, 2025, 3:50 PM
4.03
1.00%
Pre-market: Aug 15, 2025, 09:27 AM EDT

Applied DNA Sciences Cash Flow Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
Net Income
-7.09M -9.95M -8.27M -14.28M
Depreciation & Amortization
696.42K 1.36M 1.29M 844.44K
Stock-Based Compensation
572.29K 1.03M 2.52M 1.67M
Other Working Capital
-444.38K 474.69K -210.66K -230.04K
Other Non-Cash Items
-6.75M -1.11M -5.47M 1.99M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-1.14M 2.45M 954.57K -3.62M
Operating Cash Flow
-13.71M -6.22M -8.98M -13.39M
Capital Expenditures
-407.9K -78.45K -489.55K -2.55M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a 45K n/a n/a
Investing Cash Flow
-407.9K -1.1M -489.55K -2.55M
Debt Repayment
n/a n/a n/a -1.67M
Common Stock Repurchased
n/a 952.5K n/a n/a
Dividend Paid
n/a n/a -110.11K n/a
Other Financial Acitivies
394.00 n/a 3.81M 2.61M
Financial Cash Flow
13.4M n/a 18.13M 14.7M
Net Cash Flow
-720.71K -7.31M 8.66M -1.23M
Free Cash Flow
-14.12M -6.3M -9.47M -15.94M